J Surg Oncol
-
Publication Venue For
- Response to Letter to the Editor: "The impact of chemotherapy sequence on survival in node-positive invasive lobular carcinoma".. 120:566. 2019
- The impact of chemotherapy sequence on survival in node-positive invasive lobular carcinoma.. 120:132-141. 2019
- Deficiencies in postoperative surveillance for veterans with gastrointestinal cancer.. 119:273-277. 2019
- Updates in adjuvant systemic therapy for melanoma.. 119:222-231. 2019
- A preoperative prognostic model to predict surgical success in patients with perihilar cholangiocarcinoma.. 118:469-476. 2018
- Does the number of sentinel lymph nodes removed affect the false negative rate for head and neck melanoma?. 117:1584-1588. 2018
- Preoperative radiation therapy in the surgical management of gastric and junctional adenocarcinoma: Should lymph node retrieval guidelines be altered?. 117:1708-1715. 2018
- Prospective phase II trial of combination hepatic artery infusion and systemic chemotherapy for unresectable colorectal liver metastases: Long term results and curative potential.. 117:634-643. 2018
- Transected thin melanoma: Implications for sentinel lymph node staging.. 117:567-571. 2018
- Frequent BRAF mutations suggest a novel oncogenic driver in colonic neuroendocrine carcinoma.. 117:284-289. 2018
- Personalizing prognosis in colorectal cancer: A systematic review of the quality and nature of clinical prognostic tools for survival outcomes.. 116:969-982. 2017
- Socioeconomic disparities, financial toxicity, and opportunities for enhanced system efficiencies for patients with cancer.. 115:250-256. 2017
- Postoperative complications and overall survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.. 113:188-193. 2016
- Neoadjuvant use of ipilimumab in locally advanced melanoma.. 112:841-843. 2015
- Analysis of perioperative radiation therapy in the surgical treatment of primary and recurrent retroperitoneal sarcoma.. 112:352-358. 2015
- Neoadjuvant radiation therapy does not increase perioperative morbidity among patients undergoing gastrectomy for gastric cancer.. 112:46-50. 2015
- Impact of delayed lymphoscintigraphy for sentinel lymphnode biopsy for breast cancer.. 111:931-934. 2015
- Significance of diabetes on morbidity and mortality following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.. 111:740-745. 2015
- Outcomes following splenectomy in patients with myeloid neoplasms.. 111:389-395. 2015
- Examination of national lymph node evaluation practices for adult extremity soft tissue sarcoma.. 110:682-688. 2014
- Outcomes with cytoreductive surgery and HIPEC for peritoneal metastasis.. 110:575-584. 2014
- Multi-institutional analysis of recurrence and survival after hepatectomy for fibrolamellar carcinoma.. 110:412-415. 2014
- Using a modification of the Clavien-Dindo system accounting for readmissions and multiple interventions: defining quality for pancreaticoduodenectomy.. 110:400-406. 2014
- Breast conservation: is the survival better for mastectomy?. 110:58-61. 2014
- Perioperative systemic chemotherapy for appendiceal mucinous carcinoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.. 109:740-745. 2014
- Transplant versus resection for the management of hepatocellular carcinoma meeting Milan Criteria in the MELD exception era at a single institution in a UNOS region with short wait times.. 109:533-541. 2014
- Assessment of multimodality therapy use for extremity sarcoma in the United States.. 109:395-404. 2014
- Modest advances in survival for patients with colorectal-associated peritoneal carcinomatosis in the era of modern chemotherapy.. 107:307-311. 2013
- Cervical lymph node metastasis and papillary thyroid carcinoma: does the compartment involved affect survival? Experience from the SEER database.. 106:357-362. 2012
- Effect of surgeon specialization on long-term survival following colon cancer resection at an NCI-designated cancer center.. 106:219-223. 2012
- Analytic lymph node number establishes staging accuracy by occult tumor burden in colorectal cancer.. 106:24-30. 2012
- Does preoperative therapy optimize outcomes in patients with resectable pancreatic cancer?. 106:111-118. 2012
- Molecular staging individualizing cancer management.. 105:468-474. 2012
- Effect of intra-operative fluid volume on peri-operative outcomes after pancreaticoduodenectomy for pancreatic adenocarcinoma.. 105:81-84. 2012
- Lymph node ratio is an important and independent prognostic factor for patients with stage III melanoma.. 105:15-20. 2012
- Accuracy and clinical relevance of computed tomography scan interpretation of peritoneal cancer index in colorectal cancer peritoneal carcinomatosis: a multi-institutional study.. 102:565-570. 2010
- Non-ampullary duodenal adenocarcinoma: factors important for relapse and survival.. 100:144-148. 2009
- Pancreatic adenocarcinoma in a young patient population--12-year experience at Memorial Sloan Kettering Cancer Center.. 100:8-12. 2009
- A rationale for the targeted treatment of oligometastases with radiotherapy.. 98:202-206. 2008
- Impact of minimally invasive gastrectomy on use of and time to adjuvant chemotherapy for gastric adenocarcinoma. 2020
- Nationwide trends and outcomes associated with neoadjuvant therapy in pancreatic cancer: An analysis of 18 243 patients. 2017